BridgeMD
New treatment option for Postoperative Pain
Official title Postoperative Pain Monitoring With ANI in Lumbar Spine Surgery
ClinicalTrials.gov ID: NCT07455565
What this study is testing
What is Intravenous Multimodal Analgesia?
Intravenous Multimodal Analgesia is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for postoperative pain.
Also referred to as IV Multimodal Analgesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to compare two different pain management methods in patients undergoing elective lumbar spine surgery. Patients are randomly assigned to receive either an ultrasound-guided erector spinae plane block (ESPB) or intravenous multimodal analgesia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years
- ASA physical status I-II
- Scheduled for elective lumbar spine surgery
- Ability to provide informed consent
You likely can't join if
- Known allergy to study medications
- Coagulation disorders
- Infection at the block site
- Severe cardiovascular disease
- Pregnancy
- Inability to understand the study protocol
The study team makes the final eligibility decision.
Where it's taking place
- Antalya, Antalya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Antalya, Antalya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.